Youlchon Chemical Co Ltd
KRX:008730
Youlchon Chemical Co Ltd
KRX:008730
Price:
20 500
KRW
5.13%
Market Closed
Market Cap:
508.4B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Youlchon Chemical Co Ltd
20500
+1000 (+5.13%)
| 52 Week Range |
19 500
48 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Youlchon Chemical Co Ltd
Balance Sheet
Balance Sheet Decomposition
Youlchon Chemical Co Ltd
Youlchon Chemical Co Ltd
| Current Assets | 200.1B |
| Cash & Short-Term Investments | 15.4B |
| Receivables | 103.2B |
| Other Current Assets | 81.4B |
| Non-Current Assets | 458.9B |
| Long-Term Investments | 2.3B |
| PP&E | 431.3B |
| Intangibles | 12.3B |
| Other Non-Current Assets | 13B |
| Current Liabilities | 217.5B |
| Accounts Payable | 41.7B |
| Accrued Liabilities | 12.7B |
| Short-Term Debt | 104B |
| Other Current Liabilities | 59B |
| Non-Current Liabilities | 124.4B |
| Long-Term Debt | 111.2B |
| Other Non-Current Liabilities | 13.2B |
Balance Sheet
Youlchon Chemical Co Ltd
Youlchon Chemical Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
28 985
|
10 537
|
17 107
|
9 592
|
12 362
|
16 975
|
33 103
|
29 322
|
37 632
|
47 030
|
|
| Cash |
7
|
7
|
6
|
15
|
39
|
45
|
76
|
81
|
79
|
72
|
|
| Cash Equivalents |
28 978
|
10 530
|
17 101
|
9 577
|
12 323
|
16 930
|
33 027
|
29 241
|
37 553
|
46 958
|
|
| Short-Term Investments |
9 382
|
9 033
|
8 048
|
14 037
|
4 019
|
3 055
|
75
|
37 915
|
55
|
121
|
|
| Total Receivables |
136 471
|
122 500
|
131 926
|
127 687
|
132 935
|
128 146
|
125 903
|
124 837
|
115 291
|
115 686
|
|
| Accounts Receivables |
131 625
|
121 942
|
131 511
|
127 052
|
132 430
|
127 214
|
125 502
|
123 212
|
114 657
|
114 639
|
|
| Other Receivables |
4 846
|
558
|
415
|
635
|
505
|
932
|
401
|
1 625
|
634
|
1 047
|
|
| Inventory |
62 008
|
52 676
|
46 446
|
52 975
|
55 411
|
58 269
|
53 468
|
70 263
|
82 543
|
73 315
|
|
| Other Current Assets |
2 317
|
2 057
|
1 917
|
2 377
|
2 338
|
2 000
|
6 864
|
6 751
|
1 820
|
24 200
|
|
| Total Current Assets |
239 162
|
196 804
|
205 445
|
206 668
|
207 065
|
208 445
|
219 413
|
269 088
|
237 342
|
260 351
|
|
| PP&E Net |
309 165
|
301 767
|
303 087
|
351 324
|
385 060
|
371 297
|
374 188
|
379 252
|
384 373
|
396 915
|
|
| PP&E Gross |
309 165
|
301 767
|
303 087
|
351 324
|
385 060
|
371 297
|
374 188
|
379 252
|
384 373
|
396 915
|
|
| Accumulated Depreciation |
141 649
|
162 425
|
183 937
|
203 151
|
232 289
|
257 244
|
270 753
|
292 034
|
318 373
|
325 952
|
|
| Intangible Assets |
6 858
|
6 799
|
7 174
|
8 080
|
8 662
|
20 174
|
18 344
|
17 376
|
15 471
|
13 616
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
111
|
0
|
|
| Long-Term Investments |
1 701
|
450
|
739
|
792
|
610
|
578
|
486
|
825
|
931
|
2 348
|
|
| Other Long-Term Assets |
9 349
|
9 387
|
10 318
|
10 798
|
12 815
|
5 997
|
915
|
175
|
15 132
|
5 721
|
|
| Total Assets |
566 235
N/A
|
515 208
-9%
|
526 763
+2%
|
577 662
+10%
|
614 211
+6%
|
606 491
-1%
|
613 345
+1%
|
666 716
+9%
|
653 136
-2%
|
678 951
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
50 945
|
46 587
|
61 067
|
70 594
|
55 514
|
50 407
|
52 887
|
60 699
|
58 807
|
51 684
|
|
| Accrued Liabilities |
7 387
|
8 851
|
8 847
|
9 768
|
10 963
|
8 661
|
7 630
|
7 293
|
7 319
|
7 543
|
|
| Short-Term Debt |
56 462
|
42 625
|
30 000
|
78 000
|
101 103
|
24 409
|
17 654
|
5 971
|
18 808
|
16 591
|
|
| Current Portion of Long-Term Debt |
39 963
|
0
|
69 943
|
2 188
|
5 250
|
26 411
|
50 406
|
64 268
|
25 082
|
146 293
|
|
| Other Current Liabilities |
6 699
|
10 337
|
13 372
|
18 729
|
23 077
|
20 032
|
31 216
|
31 379
|
29 440
|
51 928
|
|
| Total Current Liabilities |
161 456
|
108 400
|
183 228
|
179 278
|
195 907
|
129 920
|
159 793
|
169 610
|
139 457
|
274 039
|
|
| Long-Term Debt |
69 806
|
69 875
|
0
|
39 812
|
58 562
|
112 451
|
83 262
|
131 249
|
163 055
|
84 970
|
|
| Deferred Income Tax |
16 954
|
16 222
|
14 771
|
13 866
|
11 284
|
11 254
|
9 677
|
11 244
|
10 442
|
3 772
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
201
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3 914
|
5 907
|
7 574
|
8 979
|
12 244
|
10 883
|
12 969
|
8 547
|
6 370
|
9 908
|
|
| Total Liabilities |
252 131
N/A
|
200 404
-21%
|
205 574
+3%
|
241 935
+18%
|
278 199
+15%
|
264 508
-5%
|
265 701
+0%
|
320 650
+21%
|
319 324
0%
|
372 689
+17%
|
|
| Equity | |||||||||||
| Common Stock |
14 776
|
14 776
|
14 776
|
14 776
|
14 776
|
14 776
|
14 776
|
14 776
|
14 776
|
14 776
|
|
| Retained Earnings |
290 851
|
291 536
|
297 902
|
312 522
|
311 815
|
317 721
|
323 645
|
321 574
|
309 177
|
281 613
|
|
| Additional Paid In Capital |
9 406
|
9 406
|
9 406
|
9 406
|
9 406
|
9 406
|
9 406
|
9 406
|
9 406
|
6 660
|
|
| Unrealized Security Profit/Loss |
929
|
914
|
895
|
977
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
15
|
79
|
184
|
310
|
452
|
3 213
|
|
| Total Equity |
314 104
N/A
|
314 804
+0%
|
321 189
+2%
|
335 727
+5%
|
336 012
+0%
|
341 984
+2%
|
347 643
+2%
|
346 066
0%
|
333 812
-4%
|
306 262
-8%
|
|
| Total Liabilities & Equity |
566 235
N/A
|
515 208
-9%
|
526 763
+2%
|
577 662
+10%
|
614 211
+6%
|
606 491
-1%
|
613 345
+1%
|
666 716
+9%
|
653 136
-2%
|
678 951
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
